Mani, yes, the Phase 3 trial was interventional. But real-world evidence from compassionate use patients, who were treated before, during, or after the trial, is non-interventional and can legally supplement trial data under FDA guidance.
Together, the randomized trial and real-world evidence from expanded access can support approval. You’re still mixing trial design with real-world use. Read the guidance or stop pretending you understand it.
Market Data 
Markets 
AI
